When both tibial/peroneal arteries in both legs are treated for lower extremity revascularization, what modifiers would we report?
When both tibial/peroneal arteries in both legs are treated for lower extremity revascularization, what modifiers would we report?
If both low-risk and high-risk HPV types are performed in a single assay, how would we code?
We are still confused about when to use or if to use the LT or RT modifier. Do you have a formula that we could apply based on a scenario?
How do codes 98976 and 98976 differ in reporting from RPM codes?
When is code 96367 assigned, and what, if any, documentation requirements may exist?
To provide you with the most actionable compliance and regulatory questions, we are retiring the pharmacy compliance question of the week to focus on answering more commonly asked questions that safeguard accurate coding and save reimbursement. The pharmacy archive will still be available and is accessible here. Compliance Question of the Week will continue to help you overcome compliance challenges, reduce operational waste, and optimize healthcare.
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Unlock 50% off all 2024 edition books when you order by July 5! Use the coupon code CO5024 at checkout to claim this offer!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24